Risk factors for Hepatitis C virus among high-risk populations (Intravenous drug addicts and patients with Thalassemia, Hemophilia, hemodialysis) in Mazandaran

Journal of Mazandaran University of Medical Sciences

Volumn 20, Issue 81, 2011, Pages 31-42

  Rafiei, Ali Reza ^a   Haghshenas, Mohammad Reza ^a   Azizi, Maedeh Darzyani ^a   Taheri, Sepideh ^a   Babamahmoudi, Farhang ^b   Makhlough, Atiyeh ^b   Hoseini, Seyed Hamzeh ^b  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hepatitis C; High risk group; Risk factor

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ALCOHOL CONSUMPTION; ANALYSIS OF VARIANCE; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; DEMOGRAPHY; DRUG DEPENDENCE; EPIDEMIOLOGICAL DATA; FEMALE; FREQUENCY ANALYSIS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOPHILIA; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIXED INFECTION; PRISONER; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RISK FACTOR; THALASSEMIA;

EID: 79960946502     PISSN: 17359279     EISSN: 17359260     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Ding X, Gu H, Zhong ZH, Zilong X, Tran HT, Iwaki Y, et al. Molecular epidemiology of hepatitis viruses and genotypic distribution of hepatitis B and C viruses in Harbin, China. Jpn J Infect Dis 2003; 56(1): 19-22.
2. Ramia S, Eid-Fares J. Distribution of hepatitis C virus genotypes in the Middle East. Int J Infect Dis 2006; 10(4): 272-277.
3. Ahmadi Pour MH, Sabahi F, Alavian SM. Determination of HCV Genotypes, in Iran by PCR-RFLP. Iran J Publ Health 2006; 35(4): 54-61.
4. Shaikh FH, Ali Abro H, Ali Chhutto M, Abbasi PA, Shaikh AW, Ali Buriro S. et al. frequency and risk factors associated with sero-positivity among adults in Larkana City. J Ayub Med Coll Abbottabad 2009; 21(2): 107-109.
5. Patel PR, Thompson ND, Kallen AJ, Arduino MJ. Epidemiology, surveillance, and prevention of hepatitis C virus infections in hemodialysis patients. Am J Kidney Dis 2010; 56(2): 371-378.
6. Kabir A, Keyvani H. Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study. Comp Hepatol 2006; 5(2): 4.
7. Remis R. A study to characterize the epidemiology of hepatitis C infection in Canada, 2002. Final report. Ottawa: Health Canada, 2004.
8. Makhlough A, Mahdavi M, Haghshenas M, Ghasemian R, Jamshidi M. Hepatitis C prevalence in hemodialysis patients in Mazandaran, Iran: A survey by polymerase chain reaction and serological methods. Res J Biol Sci 2008; 3(4): 265-268.
9. Wong T, Hepatitis C: a review for primary care physicians. CMAJ 2006; 174(10): 649-659.
10. WHO, Hepatitis C-global prevalence. Wkly Epidemiol Rec 2000; 75(3): 18-19.
11. Alter MJ, Gerety RJ, Smallwood L, Sampliner RE, Tabor E, Deinhardt F, Frosner G, et al. Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban United States population. J Infect Dis 1982; 145(6): 886-893.
12. Darwish MA, Faris R, Darwish N, Shouman A, Gadallah M, El-Sharkawy MS, et al. Hepatitis C and cirrhotic liver disease in the Nile delta of Egipt: a community-based study. Am J Trop Med Hyg 2001; 64(3-4): 147-153.
13. Alavian SM, Zali MR. Epidemiology of an emerging infection, Hepatitis C virus in Iran. Arch Iran Med 2005; 8(2): 84-90.
14. Khan S, Attaullah S, Ayaz S, Khan SN, Shams S, Ali I, et al. Molecular Epidemiology of HCV among Health Care Workers of Khyber Pakhtunkhwa. Virol J 2011; 8(1): 105.
15. Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 2005; 18(1): 52-61.
16. Griveas I, Germanidis G, Visvardis G, Morice Y, Perelson AS, Pawlotsky JM, et al. Acute hepatitis C in patients receiving hemodialysis. Ren Fail 2007; 29(6): 731-736.
17. Rezvan H, Abolghassemi H, Kafiabad SA. Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfus Med 2007; 17(6): 425-433.
18. Khattab OS. Prevalence and risk factors for hepatitis C virus infection in hemodialysis patients in an Iraqi renal transplant center. Saudi J Kidney Dis Transpl 2008; 19(1): 110-115.
19. Raggam RB, Rossmann AM, Salzer HJ, Stauber RE, Kessler HH. Kessler Health care worker-to-patient transmission of hepatitis C virus in the health care setting: Many questions and few answers. J Clin Virol 2009; 45(4): 272-275.
20. Hofmann JN, Törner A, Chow WH, Ye W, Purdue MP, Duberg AS. Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: a nationwide register-based cohort study in Sweden. Eur J Cancer Prev 2011; [Epub ahead of print].
21. Zamani S, Ichikawa S, Nassirimanesh B, Vazirian M, Ichikawa K, Gouya MM, et al. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. Int J Drug Policy 2007; 18(5): 359-363.
22. Vescio MF, Longo B, Babudieri S, Starnini G, Carbonara S, Rezza G, et al. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. J Epidemiol Community Health 2008; 62(4): 305-313.
23. Mohtasham Amiri Z, Rezvani M, Jafari Shakib R, Jafari Shakib A. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province. East Mediterr Health J 2007; 13(2): 250-256.
24. Silva MB, Andrade TM, Silva LK, Rodart IF, Lopes GB, Carmo TM, et al. Prevalence and genotypes of hepatitis C virus among injecting drug users from Salvador-BA, Brazil. Mem Inst Oswaldo Cruz 2010; 105(3): 299-303.
25. Zali MR, Nowroozi A. Anti-HCV antibody among Iranian IV drug users: is it a serious problem? Arch Iran Med 2001; 4(3): 115-119.
26. Flamm SL, Parker R, Chopra S. Risk factors associated with chronic hepatitis C virus infection: limited frequency of an unidentified source of transmission. Am J Gastroenterol 1998; 93(4): 597-600.
27. Mendes-Correa MC, Barone AA, Gianini RJ. Risk factors associated with hepatitis C among patients co-infected with human immuno defficency virus: a case-control study. Am J Trop Med Hyg 2005; 72(6): 762-767.
28. Paintsil E, He H, Peters C, Lindenbach BD, Heimer R. Survival of hepatitis C virus in syringes: implication for transmission among injection drug users. J Infect Dis 2010; 202(7): 984-990.
29. Fallahian F, Najafi A. Epidemiology of hepatitis C in the Middle East. Saudi J Kidney Dis Transpl 2011; 22(1): 1-9.
30. Karaca C, Cakaloǧlu Y, Demir K, Ozdil S, Kaymakoǧlu S, Badur S, et al. Risk factors for the transmission of hepatitis C virus infection in the Turkish population. Dig Dis Sci 2006; 51(2): 365-369.
31. Zeuzem S, Teuber G, Lee JH, Rüster B, Roth WK. Risk factors for the transmission of hepatitis C. J Hepatol 1996; 24(2 Suppl): 3-10.
32. Thomas DL, Zenilman JM, Alter HJ, Shih JW, Galai N, Carella AV, et al. Sexual transmission of hepatitis C virus among patients attending Baltimore sexually transmitted diseases clinics: an analysis of 309 sexual partnerships. J Infect Dis 1995; 171(4): 768-775.
33. Jabbari A, Besharat S, Khodabakhshi B. Hepatitis C in Hemodialysis Centers of Golestan Province, Northeast of Iran (2005). Hepatitis Monthly 2008; 8(1): 61-65.
34. Gogos CA, Fouka KP, Nikiforidis G, Avgeridis K, Sakellaropoulos G, Bassaris H, et al. Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece. Eur J Epidemiol 2003; 18(6): 551-557.
35. Davaalkham D, Ojima T, Nymadawa P, Uehara R, Watanabe M, Oki I, et al. Prevalence and risk factors for hepatitis C virus infection in Mongolian children: Findings from a nationwide survey. J Med Virol 2006; 78(4): 466-472.
36. Hosseini Asl SK, Avijgan M, Mohamadnejad M. High prevalence of HBV, HCV, and HIV infections in Gypsy population residing in Shahr-E-Kord. Arch Iran Med 2004. 7(1): 20-22.
37. Hajiani E, Hashemi J, Masjedizadeh R, Shayesteh AA, Idani E, Rajabi T. Seroepidemiology of hepatitis C and its risk factors in Khuzestan Province, south-west of Iran: a case-control study. World J Gastroenterol 2006; 12(30): 4884-4887.
38. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: A casecontrol study. J Gastroenterol Hepatol 2002; 17(10): 1092-1097.
39. Hajiani E, Masjedizadeh R, Hashemi J, Azmi M, Rajabi T. Hepatitis C virus transmission and its risk factors within families of patients infected with hepatitis C virus in southern Iran: Khuzestan. World J Gastroenterol 2006; 12(43): 7025-7028.
40. Martins T, Narciso-Schiavon JL, Schiavon LD. Epidemiology of hepatitis C virus infection. Rev Assoc Med Bras 2011; 57(1): 107-112.
41. Champion JK, Taylor A, Hutchinson S, Cameron S, McMenamin J, Mitchell A, Goldberg D. Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: a cohort study. Am J Epidemiol 2004; 159(5): 514-519.
42. Pereira BJ, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997; 51(4): 981-999.
43. Sandhu J, Preiksaitis JK, Campbell PM, Carriere KC, Hessel PA. Hepatitis C prevalence and risk factors in the northern Alberta dialysis population. Am J Epidemiol 1999; 150(1): 58-66.
44. Jadoul M, Cornu C, Van Ypersele de Strihou C. Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group. Kidney Int 1998; 53(4): 1022-1025.
45. Chlabicz S, Grzeszczuk A, Prokopowicz D. Medical procedures and the risk of iatrogenic hepatitis C infection: case-controlled study in north-eastern Poland. J Hosp Infect 2004; 58(3): 204-209.
46. Chlabicz S, Flisiak R, Grzeszczuk A, Kovalchuk O, Prokopowicz D, Chyczewski L. Known and probable risk factors for hepatitis C infection: a case series in northeastern Poland. World J Gastroenterol 2006; 12(1): 141-145.